Judges Scientific plc
JDG.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 7.16 | -2.49 | -21.52 | 0.78 |
| FCF Yield | 3.94% | 3.36% | 2.30% | 2.53% |
| EV / EBITDA | 19.95 | 20.62 | 19.81 | 26.22 |
| Quality | ||||
| ROIC | 7.97% | 10.24% | 12.02% | 19.98% |
| Gross Margin | 68.86% | 68.77% | 18.56% | 16.81% |
| Cash Conversion Ratio | 2.64 | 2.79 | 1.63 | 1.33 |
| Growth | ||||
| Revenue 3-Year CAGR | 5.68% | 14.24% | 12.33% | 3.43% |
| Free Cash Flow Growth | 7.28% | 67.13% | -8.27% | 27.67% |
| Safety | ||||
| Net Debt / EBITDA | 1.80 | 1.60 | 1.35 | 0.14 |
| Interest Coverage | 4.07 | 2.92 | 3.96 | 20.52 |
| Efficiency | ||||
| Inventory Turnover | 1.48 | 1.60 | 4.14 | 5.37 |
| Cash Conversion Cycle | 254.63 | 226.36 | 131.89 | 98.98 |